KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Other financing activities (2016 - 2022)

Historic Other financing activities for Abbott Laboratories (ABT) over the last 7 years, with Q1 2022 value amounting to $324.0 million.

  • Abbott Laboratories' Other financing activities rose 657.89% to $324.0 million in Q1 2022 from the same period last year, while for Sep 2025 it was -$212.0 million, marking a year-over-year decrease of 11414.14%. This contributed to the annual value of -$11.0 million for FY2020, which is 10211.13% down from last year.
  • According to the latest figures from Q1 2022, Abbott Laboratories' Other financing activities is $324.0 million, which was up 657.89% from -$536.0 million recorded in Q4 2021.
  • Over the past 5 years, Abbott Laboratories' Other financing activities peaked at $324.0 million during Q1 2022, and registered a low of -$536.0 million during Q4 2021.
  • In the last 5 years, Abbott Laboratories' Other financing activities had a median value of $99.5 million in 2019 and averaged $77.7 million.
  • Its Other financing activities has fluctuated over the past 5 years, first plummeted by 34150.94% in 2020, then skyrocketed by 14648.44% in 2021.
  • Over the past 5 years, Abbott Laboratories' Other financing activities (Quarter) stood at $81.0 million in 2018, then increased by 4.94% to $85.0 million in 2019, then crashed by 401.18% to -$256.0 million in 2020, then plummeted by 109.38% to -$536.0 million in 2021, then soared by 160.45% to $324.0 million in 2022.
  • Its last three reported values are $324.0 million in Q1 2022, -$536.0 million for Q4 2021, and $113.0 million during Q3 2021.